Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients

Conclusions: Our results provide evidence that higher CCL18 plasma levels are associated with more severe inflammatory and neurodegenerative brain MRI outcomes in MS.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research